Notice2021-20245
Steven P. French, M.D.; Decision and Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 20, 2021
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 179 (Monday, September 20, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 179 (Monday, September 20, 2021)]
[Notices]
[Pages 52205-52207]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-20245]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Steven P. French, M.D.; Decision and Order
On February 11, 2021, the Assistant Administrator, Diversion
Control Division, Drug Enforcement Administration (hereinafter,
Government), issued an Order to Show Cause (hereinafter, OSC) to Steven
P. French, M.D. (hereinafter, Registrant) of Jackson, Wyoming. OSC, at
1. The OSC proposed the revocation of Registrant's Certificate of
Registration No. FF5659505. Id. It alleged that Registrant is ``without
authority to handle controlled substances in Wyoming, the state in
which [he is] registered with DEA.'' Id. at 2 (citing 21 U.S.C.
824(a)(3)).
Specifically, the OSC alleged that the Wyoming Board of Medicine
(hereinafter, the Board) issued a Findings of Fact, Conclusions of Law,
and Order on April 17, 2020. Id. at 1. According to the OSC, the Board
accepted Registrant's voluntary relinquishment of his Wyoming medical
license following its finding, inter alia, that Registrant was
convicted of driving under the influence. Id. at 1-2. The Board further
found that during Registrant's arrest for driving under the influence,
Wyoming authorities ``discovered in [Registrant's] possession a
prescription bottle of lorazepam 0.5 mg pills belonging to one of [his]
patients, but with one pill missing.'' Id. at 2.
The OSC notified Registrant of the right to request a hearing on
the allegations or to submit a written statement, while waiving the
right to a hearing, the procedures for electing each option, and the
consequences for failing to elect either option. Id. (citing 21 CFR
1301.43). The OSC also notified Registrant of the opportunity to submit
a corrective action plan. Id. at 3 (citing 21 U.S.C. 824(c)(2)(C)).
Adequacy of Service
In a Declaration, dated July 21, 2021, a Diversion Investigator
(hereinafter, the DI) assigned to the Cheyenne Resident Office of the
Denver Field Division, stated that on September 21, 2020, prior to the
issuance of the OSC, he had communicated via email with Registrant
regarding Registrant's DEA registration. Request for Final Agency
Action (hereinafter, RFAA), Exhibit (hereinafter, RFAAX) 3 (DI's
Declaration), at 1. The DI stated that the following day,
``[Registrant] responded to the email [the DI] had sent him and
indicated that he had moved to Alaska and that for any future
communications [the DI] should contact him via email.'' Id.; see also
RFAAX 3, Appendix (hereinafter, App.) A (email exchange with
Registrant). On February 12, 2021, the DI sent a copy of the OSC to
Registrant via email. Id. at 1. The DI stated that later that day,
Registrant ``responded to [the] email and indicated that he received a
copy of the [OSC].'' Id. at 1-2; see also RFAAX 3, App. B (email from
Registrant). The DI stated that, as of July 21, 2021, ``DEA has not
received any correspondence from [Registrant] or any attorney acting on
his behalf concerning the [OSC].'' RFAAX 3, at 2.
The Government forwarded its RFAA, along with the evidentiary
record, to me on August 10, 2021. In its RFAA, the Government
represents that ``[Registrant] has not submitted a timely request for a
hearing in this matter.'' RFAA, at 1. The Government seeks to revoke
Registrant's DEA registration because ``[Registrant] lacks authority to
handle controlled substances in the State of Wyoming, the state where
he is registered with DEA.'' Id.
Based on the DI's Declaration, the Government's written
representations, and my review of the record, I find that the
Government accomplished service of the OSC on Registrant on February
12, 2021. I also find that more than thirty days have now passed since
the Government accomplished service of the OSC. Further, based on the
DI's Declaration and the Government's written representations, I find
that neither Registrant, nor anyone purporting to represent the
Registrant, requested a hearing, submitted a written statement while
waiving Registrant's right to a hearing, or submitted a corrective
action plan. Accordingly, I find that Registrant has waived the right
to a hearing and the right to submit a written statement and corrective
action plan. 21 CFR 1301.43(d) and 21 U.S.C. 824(c)(2)(C). I,
therefore, issue this Decision and Order based on the record submitted
by the Government, which constitutes the entire record before me. 21
CFR 1301.43(e).
Findings of Fact
Registrant's DEA Registration
Registrant is the holder of DEA Certificate of Registration No.
FF5659505 at the registered address of 6605 N Snake River Woods Dr.,
Jackson, WY 83001. RFAAX 1 (Certificate of Registration). Pursuant to
this registration, Registrant is authorized to dispense controlled
substances in schedules II through V as a practitioner. Id.
Registrant's registration expires on September 30, 2021. Id.
The Status of Registrant's State License
On January 16, 2020, Registrant submitted a letter to the Board
informing it that he was voluntarily relinquishing his Wyoming medical
license. RFAAX 3, App. C, at 19. On March 19, 2020, a member of the
Board petitioned the Board to accept Registrant's voluntary
relinquishment of his Wyoming Physician License. Id. at 13. On April
17, 2020, the Board issued its Findings of Fact, Conclusions of Law,
and Order Accepting Voluntary Relinquishment of the Wyoming Physician
License of Steven P. French, M.D., Wyoming Physician License No. 3068A
(hereinafter, Board Order). Id. at 1.
According to the Board Order, in September 2018, Registrant's
clinical privileges were permanently revoked by Crook County Medical
Services District in Sundance, Wyoming based upon an incident in August
2018 where Registrant was allegedly intoxicated and exhibited
``disruptive, abusive, and threatening behavior'' at the hospital while
he was off-duty. Id. at 3. When the Wyoming Medicine Board opened a
complaint on the matter, Registrant denied any inappropriate behavior
and ``asserted that he had unilaterally resigned his clinical
privileges as opposed to them being revoked.'' Id. On July 2, 2019,
while the first complaint was still pending, Registrant applied to
renew his Wyoming medical license and indicated on his application that
he ``was convicted of driving under the influence on November 26, 2018,
related to an arrest incident that occurred on July 12, 2018.'' Id.
The Board opened an additional complaint concerning the arrest
incident. Id. The Board Order states that Registrant was arrested for a
DUI at a gas station, and ``[d]uring the arrest, sheriff deputies also
located a prescription bottle of [l]orazepam 0.5 mg for 30 pills, of
which one pill was missing.'' Id. at 4. Further, ``[t]he label
indicated the prescription was written by [Registrant] for one of his
patients'' and ``[i]t was determined that the prescription was
[[Page 52206]]
filled in Sundance, Wyoming, on the same day [Registrant] was
arrested.'' Id. The Board Order states that according to the sheriff's
report, Registrant refused intoximeter breath testing for alcohol, the
sheriff deputies obtained a search warrant, and Registrant's blood was
drawn that evening indicating that Registrant had an ethyl alcohol
concentration of 0.190. Id. Further investigation by the Board found
that Registrant had three additional DUI convictions from 2008, 2012,
and 2018. Id.
The Board ordered a Clinical Professional Fitness to Practice
Evaluation of Registrant on September 26, 2019, and Registrant was
evaluated the week of November 4-7, 2019. Id. at 5. The evaluation
recommended that Registrant enter into a residential treatment program
for addiction, engage in a monitoring contract with the Wyoming
Professionals Assistance Program for the remainder of his career,
abstain from controlled substances, follow up with local outpatient
care following his treatment program, attend addiction recovery support
meetings, and explore the option of using medication with a treating
psychiatrist. Id. at 6.
According to the Board Order, on December 30, 2019, Registrant
agreed to voluntarily refrain from the practice of medicine until the
disciplinary matter was resolved. Id. However, Registrant ``refused
and/or failed to comply'' with any of the recommendations from the
evaluation. Id. Following the letter that Registrant submitted on
January 16, 2020, Registrant also emailed the Board on February 14,
2020, and wrote that he was, ``no longer a member of [the] organization
thus [the] rules and regulations no longer [applied] to [him].'' Id. at
6-7. In lieu of further disciplinary proceedings, the Wyoming Medicine
Board sought to accept Registrant's offer to voluntarily relinquish his
Wyoming medical license. Id. at 7. The Board Order accepted
Registrant's voluntary relinquishment of his Wyoming medical license
and thus ordered his authority and ability to practice medicine in
Wyoming to be relinquished. Id. at 11.
According to Wyoming's online records, of which I take official
notice, Registrant's medical license remains relinquished and
Registrant is not authorized in Wyoming to practice medicine.\1\
Wyoming Board of Medicine Physician License Search,
<a href="http://wyomedboard.wyo.gov/physicians/physician-license-look-up">wyomedboard.wyo.gov/physicians/physician-license-look-up</a> (last visited
date of signature of this Order). Id. Further, Wyoming's online
records, of which I take official notice, show that Registrant's
Wyoming individual controlled substance registration is not currently
active.\2\ Wyoming State Board of Pharmacy Licensing, <a href="https://pharmacyboard.wyo.gov/licensing/controlled-substance-reg">https://pharmacyboard.wyo.gov/licensing/controlled-substance-reg</a> (last visited
date of signature of this Order).
---------------------------------------------------------------------------
\1\ Under the Administrative Procedure Act, an agency ``may take
official notice of facts at any stage in a proceeding--even in the
final decision.'' United States Department of Justice, Attorney
General's Manual on the Administrative Procedure Act 80 (1947) (Wm.
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e),
``[w]hen an agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a party is
entitled, on timely request, to an opportunity to show the
contrary.'' Accordingly, Registrant may dispute my finding by filing
a properly supported motion for reconsideration of finding of fact
within fifteen calendar days of the date of this Order. Any such
motion and response shall be filed and served by email to the other
party and to Office of the Administrator, Drug Enforcement
Administration at <a href="/cdn-cgi/l/email-protection#690d0c0847080d0d0647081d1d061b070c101a290d0c08471c1a0d0603470e061f"><span class="__cf_email__" data-cfemail="3e5a5b5f105f5a5a51105f4a4a514c505b474d7e5a5b5f104b4d5a515410595148">[email protected]</span></a>.
\2\ See supra n.1 regarding official notice.
---------------------------------------------------------------------------
Accordingly, I find that Registrant is not currently licensed to
engage in the practice of medicine nor to handle controlled substances
in Wyoming, the state in which Registrant is registered with the DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under section 823 of the
Controlled Substances Act (hereinafter, CSA) ``upon a finding that the
registrant . . . has had his State license or registration suspended .
. . [or] revoked . . . by competent State authority and is no longer
authorized by State law to engage in the . . . dispensing of controlled
substances.'' With respect to a practitioner, the DEA has also long
held that the possession of authority to dispense controlled substances
under the laws of the state in which a practitioner engages in
professional practice is a fundamental condition for obtaining and
maintaining a practitioner's registration. See, e.g., James L. Hooper,
M.D., 76 FR 71371 (2011), pet. for rev. denied, 481 F. App'x 826 (4th
Cir. 2012); Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).
This rule derives from the text of two provisions of the CSA.
First, Congress defined the term ``practitioner'' to mean ``a physician
. . . or other person licensed, registered, or otherwise permitted, by
. . . the jurisdiction in which he practices . . . , to distribute,
dispense, . . . [or] administer . . . a controlled substance in the
course of professional practice.'' 21 U.S.C. 802(21). Second, in
setting the requirements for obtaining a practitioner's registration,
Congress directed that ``[t]he Attorney General shall register
practitioners . . . if the applicant is authorized to dispense . . .
controlled substances under the laws of the State in which he
practices.'' 21 U.S.C. 823(f). Because Congress has clearly mandated
that a practitioner possess state authority in order to be deemed a
practitioner under the CSA, the DEA has held repeatedly that revocation
of a practitioner's registration is the appropriate sanction whenever
he is no longer authorized to dispense controlled substances under the
laws of the state in which he practices. See, e.g., James L. Hooper, 76
FR at 71371-72; Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006);
Dominick A. Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D.,
53 FR 11919, 11920 (1988); Frederick Marsh Blanton, 43 FR at 27617.
Under Wyoming law, ``dispense'' means to deliver a controlled
substance to an ultimate user or research subject by or pursuant to the
lawful order of a practitioner, including the prescribing,
administering, packaging, labeling, or compounding necessary to prepare
the substance for that delivery.'' Wyo. Stat. Ann. Sec. 35-7-
1002(a)(vii) (West, current through Chs. 1 to 169 of the 2021 Regular
Session of the Wyoming Legislature). Further, ``practitioner'' means .
. . [a] physician . . . or other person licensed, registered or
otherwise permitted to distribute, dispense, conduct research with
respect to or administer a controlled substance in the course of
professional practice or research in this state.'' Id. at Sec. 35-7-
1002(a)(xx)(A). Because Registrant is not currently licensed as a
physician, or otherwise licensed, in Wyoming, he is not authorized to
dispense controlled substances in Wyoming.\3\
---------------------------------------------------------------------------
\3\ Furthermore, Wyoming law requires ``[e]very person who . . .
dispenses any controlled substance within this state . . . [to]
obtain every two (2) years, on or before July 1, a registration
issued by the board in accordance with its rules.'' Wyo. Stat. Ann.
Sec. 35-7-1024(a) (West, current through Chs. 1 to 169 of the 2021
Regular Session of the Wyoming Legislature). As found above,
Registrant's Wyoming controlled substances registration is not
active.
---------------------------------------------------------------------------
Here, the undisputed evidence in the record is that Registrant
currently does not have authority to practice medicine nor to handle
controlled substances in Wyoming. As already discussed, only a licensed
practitioner is authorized to dispense controlled substances in
Wyoming. Additionally, Registrant is not actively registered to
dispense controlled substances in Wyoming. Thus, because Registrant is
not
[[Page 52207]]
currently licensed to practice medicine nor to handle controlled
substances in Wyoming, Registrant is not eligible to maintain a DEA
registration. Accordingly, I will order that Registrant's DEA
registration be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
FF5659505 issued to Steven P. French, M.D. Further, pursuant to 28 CFR
0.100(b) and the authority vested in me by 21 U.S.C. 823(f), I hereby
deny any pending application of Steven P. French to renew or modify
this registration, as well as any other pending application of Steven
P. French, for additional registration in Wyoming. This Order is
effective October 20, 2021.
Anne Milgram,
Administrator.
[FR Doc. 2021-20245 Filed 9-17-21; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 20, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.